Schedule 13G ownership disclosure

Black Diamond Therapeutics Inc

Security class unavailable · CUSIP: 09203E105

Event date: 2024-06-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
10,659,730
Percent of class
18.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001897612-24-001375
Form type
SC 13G/A
Filer
Black Diamond Therapeutics, Inc.
CIK
CIK 1701541
Filed
Jul 10, 2024
Reporting period
Jun 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub